In a 21‑year‑old female with acute edematous pancreatitis, peri‑portal lymphadenopathy, recent empiric anti‑tubercular therapy, low serum calcium, triglycerides 394 mg/dL, and new generalized tonic‑clonic seizures, what is the appropriate next line of management?

Immediate Management Priority: Stop Anti-Tubercular Therapy and Investigate Underlying Etiology

This patient requires immediate discontinuation of empiric anti-tubercular drugs, comprehensive workup for autoimmune pancreatitis (particularly IgG4-related disease), and urgent neurological evaluation for the new-onset seizures in the context of recurrent pancreatitis with systemic manifestations.

Critical Clinical Assessment

This 21-year-old presents with a complex syndrome requiring systematic evaluation:

Seizure Management Takes Priority

• New GTCS with normal MRI but EEG showing encephalopathy demands immediate attention
• Normal ammonia excludes hepatic encephalopathy despite cholestatic pattern
• Corrected calcium is normal, ruling out hypocalcemic seizures
• Consider:
  • Autoimmune encephalitis (given systemic inflammatory picture)
  • Cerebral vasculitis (associated with autoimmune conditions)
  • Metabolic derangements from recurrent pancreatitis
  • Anti-epileptic therapy should be initiated while investigating underlying cause

Pancreatitis Etiology Investigation

The empiric anti-tubercular therapy should be stopped immediately 1. The clinical picture does NOT support tuberculosis:

• No ascites or terminal ileal thickening on CT 2
• Subcentimetric periportal lymphadenopathy alone is non-specific
• Recurrent pancreatitis pattern suggests alternative diagnosis

Priority workup must include:

1. Autoimmune Pancreatitis (Type 1 IgG4-related) - Most likely given:

   • Young female with recurrent episodes
   • Periportal lymphadenopathy
   • Systemic manifestations (arthralgia, fever)
   • Order immediately: Serum IgG4 levels 3
   • Consider repeat contrast-enhanced CT to assess for "sausage-shaped" pancreas characteristic of AIP

2. Hypertriglyceridemia - Partially addressed:

   • Triglycerides 394 mg/dL is elevated but below the typical 1,000 mg/dL threshold for causing pancreatitis 4, 5
   • However, in context of recurrent episodes, this warrants aggressive management
   • Start fibrate therapy immediately (fenofibrate or gemfibrozil)
   • Consider insulin infusion if triglycerides rise further 6

3. Systemic Lupus Erythematosus or other connective tissue disease:

   • Bilateral knee pain (arthralgia) for 7 months
   • Fever pattern
   • Young female
   • Order: ANA, anti-dsDNA, complement levels (C3, C4), anti-Smith antibodies

4. Drug-induced pancreatitis:

   • Review ALL medications started in past 6-12 months
   • Common culprits: thiazides, azathioprine, valproic acid, steroids 7

Immediate Management Protocol

Level of Care

Transfer to ICU or HDU immediately 1. This patient has:

• Recurrent pancreatitis with complications
• New neurological manifestations (seizures)
• Systemic inflammatory syndrome (fever, lymphadenopathy)
• Lipase >3× ULN with fat stranding on imaging

Pancreatitis-Specific Management

1. Aggressive fluid resuscitation 8, 9, 10:

   • Goal-directed therapy with crystalloids
   • Target urine output >0.5 mL/kg/hr
   • Monitor for fluid overload given young age

2. Early oral feeding 8, 9:

   • Do NOT keep NPO
   • Start low-fat diet as tolerated
   • If intolerant, use nasogastric (not nasojejunal) enteral feeding 1

3. NO prophylactic antibiotics 1, 8, 9:

   • Current guidelines do not support routine antibiotic use
   • Only use if documented infection develops
   • Stop any empiric antibiotics currently running

4. Pain management:

   • Adequate analgesia with opioids as needed
   • Patient-controlled analgesia acceptable 5

Triglyceride Management

• Start fibrate immediately (fenofibrate 145-200 mg daily)
• Add omega-3 fatty acids (4 grams daily) 6
• Strict low-fat diet (<20 grams fat/day)
• If triglycerides rise >1,000 mg/dL: consider insulin infusion (0.1-0.3 units/kg/hr with dextrose) 4, 5, 6

Neurological Management

• Anti-epileptic drug: Start levetiracetam 500-1000 mg BID (preferred in acute setting, no hepatic metabolism)
• Continuous EEG monitoring if available
• Autoimmune encephalitis workup:
  • Anti-NMDA receptor antibodies
  • Anti-LGI1, CASPR2 antibodies
  • Paraneoplastic panel
• Lumbar puncture if no contraindications (check for pleocytosis, elevated protein, oligoclonal bands)

Diagnostic Workup Timeline

Within 24 hours:

• Serum IgG4 levels
• Complete autoimmune panel (ANA, anti-dsDNA, complement, RF, anti-CCP)
• Lipid panel (repeat fasting when stable)
• Genetic testing for familial hypertriglyceridemia if indicated
• Autoimmune encephalitis antibodies

Within 48-72 hours:

• Repeat contrast-enhanced CT abdomen if IgG4 elevated (assess pancreatic morphology)
• Consider MRCP if biliary etiology still unclear (though already done)
• Lumbar puncture for CSF analysis

Within 1 week:

• If IgG4 elevated and imaging supportive: Consider empiric corticosteroid trial (prednisolone 0.6-1 mg/kg/day) 3
• Endoscopic ultrasound with fine-needle aspiration of lymph nodes if diagnosis remains unclear
• Genetic counseling and testing for hereditary pancreatitis genes (PRSS1, SPINK1, CFTR) given young age and recurrent episodes

Critical Pitfalls to Avoid

1. Do not continue anti-tubercular therapy without tissue diagnosis - This can mask autoimmune disease and delay appropriate treatment
2. Do not attribute seizures solely to metabolic causes - Normal calcium and ammonia mandate broader workup
3. Do not delay IgG4 testing - This is the most likely unifying diagnosis and requires specific treatment
4. Do not use prophylactic antibiotics - No evidence of benefit and may complicate management 1, 8
5. Do not keep patient NPO - Early feeding improves outcomes 8, 9

Expected Clinical Course

• If autoimmune pancreatitis: Dramatic response to corticosteroids within 2-4 weeks
• If hypertriglyceridemia-induced: Improvement with triglyceride control over days
• Seizures should be controlled with AED while investigating underlying cause
• Definitive diagnosis is essential - This patient is too young for "idiopathic" classification without exhaustive workup 1